| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $2.71B | -2.0% |
| Cost of Revenue | $1.92B | -4.7% |
| R&D Expense | $24.0M | -4.0% |
| SG&A Expense | $631.0M | -4.7% |
| Operating Income | $109.0M | +18.5% |
| Pre-tax Income | $85.0M | -41.4% |
| Income Tax | $13.0M | -62.9% |
| Net Income | $72.0M | -34.5% |
| EPS (Basic) | $0.83 | -35.2% |
| EPS (Diluted) | $0.82 | -35.9% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.0M | -55.1% |
| Accounts Receivable | $199.0M | -18.4% |
| Inventory | $353.0M | +2.3% |
| Current Assets | $619.0M | -12.3% |
| Total Assets | $1.96B | +3.9% |
| Current Liabilities | $841.0M | +0.6% |
| Long-term Debt | $460.0M | -5.5% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $100.0M | -76.3% |
| Capital Expenditures | $129.0M | -14.0% |
| Investing Cash Flow | -$129.0M | +11.6% |
| Financing Cash Flow | -$16.0M | +91.5% |
| Free Cash Flow | -$29.0M | -110.7% |
| Stockholders' Equity |
| $317.0M |
| +5.7% |